We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Asserts Seroquel Patent Against Teva

Law360 (June 29, 2007, 12:00 AM EDT) -- AstraZeneca Pharmaceuticals filed a lawsuit against Teva Pharmaceutical Industries Ltd. in a New Jersey court Thursday over a patent for AstraZeneca's multibillion-dollar anti-psychotic drug Seroquel.

AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP filed the lawsuit in the U.S. District Court for the District of New Jersey against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA Inc.

At issue in the suit is U.S. Patent Number 4,879,288, entitled “Novel Dibenzothiazepine Antipsychotic,” held by AstraZeneca Pharmaceuticals. The '288 patent had been slated to expire on March 20, 2007,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.